Mirae Asset Global Etfs Holdings Ltd. Design Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 17,957 shares of DSGN stock, worth $74,162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,957
Previous 17,197
4.42%
Holding current value
$74,162
Previous $92,000
19.57%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DSGN
# of Institutions
97Shares Held
32.1MCall Options Held
4.6KPut Options Held
2.6K-
Sr One Capital Management, LP6.53MShares$27 Million14.99% of portfolio
-
Logos Global Management LP San Francisco, CA4.22MShares$17.4 Million3.42% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$9.52 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.95MShares$8.07 Million0.72% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.86MShares$7.67 Million0.03% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $230M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...